TP53 and cancer: Perhaps the most interesting of these genes is the proto-oncogene MDM2, an E3 ubiquitin ligase that acts as a negative regulator of the p53 protein (Marine and Lozano, 2010), whose overexpression has been reported in many different cancer types (Rayburn et al., 2005).